Akebia Therapeutics, Inc.
AKBA
$0.88
$0.033.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.67M | -20.51M | -5.35M | -15.91M | -36.48M |
| Total Depreciation and Amortization | 1.55M | 1.28M | 1.27M | 10.29M | 19.35M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.34M | 57.94M | 55.60M | 46.64M | 50.24M |
| Change in Net Operating Assets | 20.33M | 21.66M | 16.47M | -8.63M | -35.51M |
| Cash from Operations | 41.55M | 60.37M | 67.99M | 32.40M | -2.40M |
| Capital Expenditure | -1.29M | -335.00K | -291.00K | -223.00K | -148.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 172.00K | 172.00K | 172.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.81M | -7.81M | -7.81M | -- | -- |
| Cash from Investing | -12.10M | -8.14M | -7.93M | -51.00K | 24.00K |
| Total Debt Issued | 0.00 | 0.00 | 10.00M | 10.00M | 10.00M |
| Total Debt Repaid | -5.85M | -4.35M | -4.23M | -461.00K | -461.00K |
| Issuance of Common Stock | 4.65M | 3.05M | 68.36M | 90.62M | 91.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.00M | -1.64M | -1.21M | -63.00K | -585.00K |
| Cash from Financing | -11.20M | -2.94M | 72.93M | 100.10M | 100.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.26M | 49.29M | 132.99M | 132.45M | 97.83M |